EUVIMEDOdkrijte EUVIMED
Crossref

Government Royalties on Sales of Pharmaceutical and Other Biomedical Products Developed with Substantial Public Funding: Illustrated with the Technology Transfer of the Drug-Eluting Coronary Stent

Robert S. Danziger, John T. Scott

Annals of Science and Technology Policy · 2021

DOI: 10.1561/110.00000020 ↗

At a glance

Journal article in Annals of Science and Technology Policy, 2021. Written by Robert S. Danziger and 1 co-authors. Cited 5 times so far (Crossref).

PovzetekBibliografski podatkiCiteRelated studies

Abstract (original language)

There is an ongoing policy debate across many countries about the returns to investments in publicly funded R&D. However, much of that debate is based on conjecture rather than empirical facts. Unlike the literature that focuses on the returns to investments in privately funded R&D activity, empirical estimates of the returns to publicly funded R&D are limited. This monograph focuses on one group of public sector organizations that is not only R&D intensive but also that has the potential to enrich economic growth and development in the United States; namely, Federally Funded Research and Development Centers (FFRDCs). Herein, the limited literature on the returns to public sector returns to R&D is reviewed, this legislative history of FFRDCs is presented, and the social benefits associated with FFRDC research James A. Cunningham and Albert N. Link (2022), “The Returns to Publicly Funded R&D: A Study of U.S. Federally Funded Research and Development Centers”, Annals of Science and Technology Policy: Vol. 6, No. 3, pp 228–314. DOI: 10.1561/110.00000023. ©2022 J. A. Cunningham and A. N. Link Full text available at: http://dx.doi.org/10.1561/110.00000023

Cite

APA

Danziger, R. S., & Scott, J. T. (2021). Government Royalties on Sales of Pharmaceutical and Other Biomedical Products Developed with Substantial Public Funding: Illustrated with the Technology Transfer of the Drug-Eluting Coronary Stent. Annals of Science and Technology Policy. https://doi.org/10.1561/110.00000020

Vancouver

Danziger RS, Scott JT. Government Royalties on Sales of Pharmaceutical and Other Biomedical Products Developed with Substantial Public Funding: Illustrated with the Technology Transfer of the Drug-Eluting Coronary Stent. Annals of Science and Technology Policy. 2021. doi:10.1561/110.00000020

BibTeX
@article{Danziger2021,
  author = {Danziger, Robert S. and Scott, John T.},
  title = {Government Royalties on Sales of Pharmaceutical and Other Biomedical Products Developed with Substantial Public Funding: Illustrated with the Technology Transfer of the Drug-Eluting Coronary Stent},
  journal = {Annals of Science and Technology Policy},
  year = {2021},
  doi = {10.1561/110.00000020}
}
Start for free →